Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
about
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeThe injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaquesProtection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.Hormonal contraception and HIV acquisition: reanalysis using marginal structural modelingThe cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment.Protein-coated nanoparticles are internalized by the epithelial cells of the female reproductive tract and induce systemic and mucosal immune responses.Hormonal contraception and HIV-1 transmission.Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeResponses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristicsAbrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infectionRNA interference for the treatment of papillomavirus disease.Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanismsLower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCsPsychological stress exacerbates primary vaginal herpes simplex virus type 1 (HSV-1) infection by impairing both innate and adaptive immune responses.A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virusEffects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface.Estradiol improves genital herpes vaccine efficacy in mice.HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.Gender specific differences in the immune response to infection.The roles of the immune system in women's reproduction: evolutionary constraints and life history trade-offs.Influence of common mucosal co-factors on HIV infection in the female genital tract.Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
P2860
Q28391567-A3CF1C01-BC66-44DE-9726-7A886E0A28E4Q33631772-CA78A5ED-1AB8-4D4C-895E-3904AED9829CQ33763511-6EB68CAF-4DA2-45A5-AEEB-93B2D759E96DQ33779655-29818E6A-D470-4770-8723-0023D5C0EAA8Q33788861-A9CD131D-C52F-495C-900D-4615697AB648Q33827820-E847958D-A2B7-4643-8DB4-8A372C04406CQ33835473-2AC94177-0CBD-45AE-B35A-1C91F3D988E1Q33835479-E4B4FB3F-1395-47AF-845A-D22EF9E086E1Q34123283-A9B510AC-6832-48F7-BDBD-24E3311F968EQ34142834-0CBFD438-A416-44EA-B817-AD01294ACDE1Q34194679-F8CB1BA8-BE17-4E93-BAE3-C860057345B4Q34339797-513CD40A-3116-4DBC-97DF-29A8DC86BE3EQ34627575-3117191A-4903-432F-89EF-E730E6A05271Q34663077-2294B82C-6C30-4888-A0F6-B9E49FAAF172Q34679705-CDB83EB9-9B07-4E02-9F75-C78C16083664Q35019917-C004BC2B-725A-4FC4-92A2-DE0B89569CEBQ35101507-FDD78467-7F18-4153-9F63-D28C7138F448Q35105449-F7904092-CE47-4E28-BCBD-DD0F8FE1B588Q35113308-824C89D4-FA45-4FDF-829F-C076E64C3AE6Q35201175-041C5D51-58CA-4236-997E-EEA7FC00522DQ35871689-2E32F67C-36E3-48BF-B4D5-2CB2DB926E14Q35903676-2FFEABAA-E6BE-46A4-A641-293ED2F3E814Q36105943-95F6C85C-EEC3-4B24-AB50-C561F21FAFD3Q36126206-DBDF248C-0291-40EC-9448-5EFC84FCBF25Q36252465-B18395AE-3BED-42FB-B9C2-FFF9BE97D064Q36540664-9F7D4018-90D4-42CE-A83C-BFD74ED3D2D2Q36628484-27A1B4C6-D0BE-4B95-8D26-18B06A454C92Q36654106-A3BDF495-030C-4EF1-AB1C-F1AA3CBA83C5Q36921898-03FC06EC-B3F2-465D-8C76-07D131C11741Q37041253-7513731B-4DC3-4DDD-8492-735315E92C6FQ37108089-41761C47-34DF-44E5-931E-D0DAC5621BB7Q37180994-B7A8049F-76E5-4363-AA3D-7A51E53113A7Q37281753-12A73795-91B9-4D45-BD6F-8494559D99D6Q37359132-40709C99-F059-4AD2-965D-DE8B8A8098A1Q37611796-AA534591-6BF1-439F-8D83-BAD1F5EB0496Q37858452-6F09CA67-07EC-4BD7-A0BB-128DA26FC81AQ37958705-EE79E3AC-491F-4B7D-8DE8-E88132EB027FQ38195075-7235B016-6C1E-4C66-B86A-AF145DAE2395Q38858718-FA9D8FE7-D846-430F-BD00-D68C7731EBD0Q38968366-AA280AAD-A8F4-482E-B9D7-9350790C1C39
P2860
Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@ast
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@en
type
label
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@ast
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@en
prefLabel
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@ast
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@en
P2093
P2860
P1433
P1476
Prolonged exposure to progeste ...... d herpes simplex virus type 2.
@en
P2093
Ali A Ashkar
Amy E Gillgrass
Charu Kaushic
Kenneth L Rosenthal
P2860
P304
P356
10.1128/JVI.77.18.9845-9851.2003
P407
P577
2003-09-01T00:00:00Z